🇺🇸 FDA
Pipeline program

ANM T30 CR®-System

NCT2011-08-26

Approved other completed

Quick answer

ANM T30 CR®-System for Tinnitus is a Approved program (other) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Adaptive Biotechnologies Corp
Indication
Tinnitus
Phase
Approved
Modality
other
Status
completed

Clinical trials